Case Report: Palliative Care for Metastatic triple negative Breast Cancer with Cutaneous Involvement

Case Report: Palliative Care for Metastatic triple negative Breast Cancer with Cutaneous Involvement

Saved in:

Bibliographic Details
Main Authors:	Kaylee Scarnati, Katherine Esser, Katie Beier, Thanuja Neerukonda
Format:	Article
Language:	English
Published:	The University of Toledo 2025-06-01
Series:	Translation
Subjects:	metastatic cancer breast cancer Triple negative breast cancer palliative care cutaneous metastasis
Online Access:	http://openjournals.utoledo.edu/index.php/translation/article/view/1419
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Eribulin Effectiveness and Safety in Metastatic Triple-Negative Breast Cancer: A Narrative Review
by: Herleeyana Meriyani, et al.
Published: (2025-02-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Plasma exosomes in insulin resistant obesity exacerbate progression of triple negative breast cancer
by: Pablo Llévenes, et al.
Published: (2025-07-01)

Clinical case of torpid course of metastatic triple negative breast cancer
by: E. P. Kulikov, et al.
Published: (2022-03-01)

MMP14 and DDR2 are potential molecular markers for metastatic triple-negative breast cancer
by: Rabeah Al-Temaimi, et al.
Published: (2025-07-01)

The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast Cancer: A Multicenter Cross-Sectional Study in Indonesia
by: Jeffry Beta Tenggara, et al.
Published: (2024-01-01)

c-MYC Levels and Metabolic Parameters in Triple-Positive and Triple-Negative Breast Cancer
by: Doaa N. Abood, et al.
Published: (2025-06-01)

Targeting TUBB2B inhibits triple-negative breast cancer growth and brain-metastatic colonization
by: Qingling He, et al.
Published: (2025-02-01)

Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study
by: Yun-Yi Wang, et al.
Published: (2025-08-01)

Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
by: Ahmet Necati Sanli, et al.
Published: (2024-04-01)

Implanted Microneedles Loaded with Sparfloxacin and Zinc‐Manganese Sulfide Nanoparticles Activates Immunity for Postoperative Triple‐Negative Breast Cancer to Prevent Recurrence and Metastasis
by: Zhaoyou Chu, et al.
Published: (2025-04-01)

IQGAP1 is a Specific Target of Haldol in Triple Negative Breast Cancer
by: Mahmood Meqdad
Published: (2025-06-01)

Cytokeratin expression in breast cancer: from mechanisms, progression, diagnosis, and prognosis to therapeutic implications
by: Ensiyeh Bahadoran, et al.
Published: (2025-12-01)

Anti-cancer effects of frankincense methanolic extract on brain metastatic breast cancer cells
by: Mohammad Kamalabadi-Farahani, et al.
Published: (2025-01-01)

The R-RAS2 GTPase is a signaling hub in triple-negative breast cancer cell metabolism and metastatic behavior
by: Claudia Cifuentes, et al.
Published: (2025-04-01)

Triple-negative breast cancer: Pattern of recurrence and survival outcomes
by: Shyny Reddy Chintalapani, et al.
Published: (2019-01-01)

Analysis of survival differences in advanced triple-negative breast cancer: a real-world study
by: Jun-Sheng Zheng, et al.
Published: (2025-08-01)

The Role of Genomics and Transcriptomics in Characterizing and Predicting Patient Response to Treatment in Triple Negative Breast Cancer (TNBC)
by: Franklin Eduardo Corea-Dilbert, et al.
Published: (2025-04-01)

Interleukin-12 Inhibits Tumor Growth and Metastasis Promoted by Tumor-Associated Mesenchymal Stem Cells in Triple-Negative Breast Cancer
by: Babak Jahangiri, et al.
Published: (2024-09-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

Predictive value of androgen receptor in distant metastasis of triple-negative breast cancer: a retrospective multi-center study
by: Yiwei Zeng, et al.
Published: (2025-07-01)

Evaluating the impact of a tertiary multidisciplinary meeting in metastatic breast cancer: A prospective study
by: Belinda Sassé, et al.
Published: (2025-02-01)

DLAT promotes triple-negative breast cancer progression via YAP1 activation
by: Diya Liu, et al.
Published: (2024-12-01)

Giant triple negative pregnancy-associated breast cancer (PABC) in a young woman: From diagnosis to therapy step by step: A case report
by: Micol Bottalico, et al.
Published: (2025-03-01)

Knowledge mapping of ultrasound technology and triple-negative breast cancer: a visual and bibliometric analysis
by: Yonglin Wan, et al.
Published: (2025-07-01)

RSL3 induces ferroptosis by activating the NF-κB signalling pathway to enhance the chemosensitivity of triple-negative breast cancer cells to paclitaxel
by: Jialin Yuan, et al.
Published: (2025-01-01)

Central nervous system relapse in triple-negative breast cancer patients achieving pathological complete response after neoadjuvant chemotherapy: A retrospective cohort analysis
by: Gabriel Berlingieri Polho, et al.
Published: (2025-10-01)

Role of proteasome system in prognosis of breast cancer progression
by: E. E. Shashova, et al.
Published: (2018-09-01)

Clinical Significance of Tumor Grade in Triple-Negative Breast Cancer: A Retrospective Cohort Analysis
by: Neya Ramanan, et al.
Published: (2025-05-01)

Partial Response Achieved in a Case of Metastatic Triple-Negative Breast Cancer Based on the Patient-Derived Tumor Organoids
by: Liu Y, et al.
Published: (2025-07-01)

Photodynamic therapy for metastatic breast cancer
by: E. V. Horanskaya, et al.
Published: (2014-06-01)

Androgen receptor expression in triple negative breast cancer - Study from a tertiary health care center in South India
by: Rashmi Patnayak, et al.
Published: (2018-01-01)

Results of combination treatment for triple-negative breast cancer
by: M. A. Sekundova, et al.
Published: (2014-07-01)

Role of Glucocorticoid Receptor in Triple-Negative Breast Cancer
by: Raj Kumar
Published: (2025-04-01)

Comparison of neoadjuvant and adjuvant chemotherapy for operable triple-negative breast cancer before the era of immune checkpoint inhibitors: A retrospective study from the Japanese National Clinical Database-Breast Cancer Registry
by: Tomoe Taji, et al.
Published: (2025-06-01)

The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
by: Chikako Funasaka, et al.
Published: (2025-01-01)

The integrated single-cell analysis interpret the lactate metabolism-driven immune suppression in triple-negative breast cancer
by: Xinhai Gao, et al.
Published: (2025-05-01)

PCSK9 Promotes the Malignancy of Triple‐negative Breast Cancer Cells by Reducing Cholesterol Levels at the Plasma Membrane to Activate EGFR and HER3
by: Tianhong Li, et al.
Published: (2025-05-01)

Diagnostic utility of ultrasound features in identifying triple-negative breast cancer
by: Jampana Sahitya, et al.
Published: (2025-05-01)

TQFL19, a Novel Derivative of Thymoquinone (TQ), Plays an Essential Role by Inhibiting Cell Growth, Metastasis, and Invasion in Triple-Negative Breast Cancer
by: Ali El-Far, et al.
Published: (2025-02-01)